Maternal immune dysregulation is increasingly recognised as a...

Elevated inflammatory signalling, autoantibody production, and oxidative stress during gestation may disrupt fetal brain development.
Let’s break down the biological mechanisms linking immune dysregulation to Autism Spectrum Disorder (ASD). 👇🧵
Maternal cytokines such as IL-6, IL-1β, and TNF-α can cross the placenta or signal through secondary messengers.
These influence fetal brain development by altering neuronal migration, synapse formation, and myelination.
Elevated IL-6 has been associated with altered cortical connectivity in animal models.
The placenta expresses receptors for maternal cytokines and plays a key role in mediating the inflammatory response.
Placental inflammation can impair nutrient transport, modulate hormone release, and prime fetal microglia.
Microglia guide synaptic pruning and neuroplasticity.
Maternal immune activation may lead to microglial overactivation, resulting in disrupted neural circuit refinement, one of the key findings in ASD brain tissue studies.
Some mothers of autistic children produce autoantibodies targeting fetal brain proteins.
These antibodies may cross the placenta and interfere with neural development, especially during critical windows of gestation.
This subset is being studied under "maternal autoantibody-related (MAR) autism."
Maternal immune activation can increase oxidative stress and reduce antioxidant capacity.
This affects neuronal differentiation and mitochondrial integrity, both implicated in ASD neuropathology.
Maternal inflammation may also dysregulate key neurodevelopmental pathways involving growth factors, such as IGF and BDNF, and axon guidance cues.
These changes can impair long-range connectivity in the fetal brain.
Male fetuses may be more susceptible to immune-mediated alterations.
This may relate to differential microglial activation, sex hormone interaction, or timing of developmental windows.
ASD affects males ~4× more often—immune vulnerability is one proposed contributor.
Maternal immune dysregulation is one of several converging risk pathways in ASD.
It may shape long-term neural outcomes via cytokine signalling, oxidative stress, and antibody interference.
Join over 23,000 clinicians subscribed to the Psych Scene newsletter, expert commentary, diagnostic frameworks, and clinically relevant insights tailored for psychiatrists.
psychscene.co/42kdxsP
